Safeguarding public health – Article from #1 2019

INTRODUCTION In a world with an estimated population of 7.6 billion, 2 billion people lack access to medicines that are imperative to their health and survival. Consequently, 15,000 deaths per day (more than half of the 5.6 million children who died before their fifth birthday in 2016) could have been prevented with the provision of essential health services. In total, […] Read More

In Pursuit of Robinson Crusoe – Article from #1 2019

Naming pharmaceuticals is a topic that has been thoroughly investigated and buzzed around, and where the world’s expertise agrees on at least one thing. With today’s increasingly dense jungle of brands, combined with the famously strict regulations of authorities such as the European Medicines Agency (EMA), the US Food and Drug Administration (FDA) and the WHO (World Health Organization), the […] Read More

The CJEU clarifies – Article from #1 2019

INTRODUCTION Where to draw the line between the protection of new innovations within the pharmaceutical area, on the one hand, and the generic companies’ right to enter the market on the other, has been subject to discussion in patent law for a long time. The innovative pharmaceutical companies’ right to exclusively capitalise on their innovative research stands against the generic […] Read More


Welcome to the Stockholm IP Law Review seminar and dinner IP Pharma Challenges in 2019 Patents and Trademarks – Trends and Case Law To celebrate the Master Student Class of 2018/19. The seminar will take place on June 4, at 15:00. Please see the invitation here below. View PDF RSVP Warm regards, The Stockholm IP Law Review

Save The Date

The Stockholm IP Law Review is pleased to announce its summer seminar on the current topic of: IP Pharma Challenges in 2019 Patent and trademarks – Trends and case law The seminar will take place in the afternoon of June 4, 2019 at Stockholm University and we hope that you would reserve that date to join us in the discussions. […] Read More